BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37856402)

  • 21. Flow volume mismatch dramatically affects transient neurologic symptoms after direct bypass in Moyamoya disease.
    Maeda Y; Okazaki T; Kume S; Kawano R; Takauchi K; Hara T; Kuwabara M; Hiroshi K; Daizo I; Horie N
    Neurosurg Rev; 2023 Oct; 46(1):274. PubMed ID: 37847310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2019 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease.
    Czabanka M; Peña-Tapia P; Scharf J; Schubert GA; Münch E; Horn P; Schmiedek P; Vajkoczy P
    Cerebrovasc Dis; 2011; 32(4):361-9. PubMed ID: 21921600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-dependent revascularization patterns in the treatment of moyamoya disease in a European patient population.
    Czabanka M; Vajkoczy P; Schmiedek P; Horn P
    Neurosurg Focus; 2009 Apr; 26(4):E9. PubMed ID: 19335135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic study about cortical hyperintensity belt sign after direct bypass surgery for moyamoya disease.
    Takemoto Y; Kawano T; Ohmori Y; Kaku Y; Uekawa K; Amadatsu T; Hayashi K; Kitajima M; Mukasa A
    J Clin Neurosci; 2020 Apr; 74():124-129. PubMed ID: 32070671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Induced Hypertension and Hypervolemia in Preventing Neurologic Complications After Combined Direct and Indirect Bypass in Hemorrhagic-Onset Moyamoya Disease.
    Li Y; Wang AR; Steinberg GK
    World Neurosurg; 2022 Apr; 160():e381-e387. PubMed ID: 35026459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative neovascularization, cerebral hemodynamics, and clinical prognosis between combined and indirect bypass revascularization procedures in hemorrhagic moyamoya disease.
    Sun J; Li ZY; Chen C; Ling C; Li H; Wang H
    Clin Neurol Neurosurg; 2021 Sep; 208():106869. PubMed ID: 34419781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.
    Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK
    J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality.
    Lee SB; Kim DS; Huh PW; Yoo DS; Lee TG; Cho KS
    Acta Neurochir (Wien); 2012 Jul; 154(7):1179-87. PubMed ID: 22476796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ipsilateral late stroke after revascularization surgery for patients with Moyamoya disease.
    Araki Y; Yokoyama K; Uda K; Kanamori F; Mamiya T; Nishihori M; Sumitomo M; Okamoto S; Izumi T
    Acta Neurochir (Wien); 2021 May; 163(5):1493-1502. PubMed ID: 33624115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronological Volume Changes of the Temporal Muscle Pedicle Used for Encephalo-myo-synangiosis in Combined Revascularization for Moyamoya Disease: A Prospective Observational Study.
    Mizushima M; Ito M; Fujima N; Uchino H; Sugiyama T; Fujimura M
    Neurol Med Chir (Tokyo); 2023 Jul; 63(7):304-312. PubMed ID: 37081648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of superficial temporal artery to middle cerebral artery bypass on postoperative infarction rates among young children (≤ 5 years old) with moyamoya disease.
    Takasu S; Kanamori F; Hatano N; Seki Y; Saito R
    Neurosurg Rev; 2023 Apr; 46(1):87. PubMed ID: 37067615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy.
    Nielsen TH; Abhinav K; Sussman ES; Han SS; Weng Y; Bell-Stephens T; ; Heit JJ; Steinberg GK
    J Neurosurg; 2020 Jun; 134(5):1578-1589. PubMed ID: 32534489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usefulness and safety of dexmedetomidine for postoperative sedation in pediatric patients with moyamoya disease.
    Kanamori F; Araki Y; Yokoyama K; Uda K; Kurimoto M; Shiba Y; Mamiya T; Takayanagi K; Ishii K; Nishihori M; Izumi T; Okamoto S; Saito R
    J Neurosurg Pediatr; 2022 Sep; 30(3):301-307. PubMed ID: 35901711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
    Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
    World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research progress on postoperative transient neurological dysfunction in pediatric and adult patients with moyamoya disease after revascularization surgery.
    Chen JY; Tu XK
    Clin Neurol Neurosurg; 2022 Jun; 217():107254. PubMed ID: 35512575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Cerebral Infarction Early After Revascularization in Children Younger than 5 Years with Moyamoya Disease.
    Araki Y; Uda K; Yokoyama K; Kanamori F; Kurimoto M; Shiba Y; Mamiya T; Nishihori M; Takeuchi K; Tanahashi K; Nagata Y; Nishimura Y; Okamoto S; Sumitomo M; Izumi T; Saito R
    World Neurosurg; 2022 Apr; 160():e220-e226. PubMed ID: 34995829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
    Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
    J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.